12.2.2021 15:26:24 CET | Aqua Bio Technology ASA | Inside information

Aqua Bio Technology ASA (ABT) has today signed an distribution agreement with 
Galaxa Pharma Aps [https://www.galaxapharma.com/] (Galaxa). The agreement grants
Galaxa distribution rights for Denmark for the certified organic skincare line
Moana Skincare. ABT has previously announced its acquisition of all rights to
Moana Skincare [https://newsweb.oslobors.no/message/513213].

Galaxa has since 2014 been commercially active in Denmark as a representative of
various foreign producers, with sales through drugstores (Matas), pharmacies and
its own web shop [https://cosmage.dk/]. Today Galaxa has product series within
skincare and anti-aging, medical device approved cannabis products and eyelash &
brow products based on active Ingredients from eye medicine. Galaxa has since
2014 established a distribution model that covers approx. 200 stores.

"We are pleased to have entered into a distribution agreement with Galaxa.
Galaxa has an interesting and very forward-looking business model and we believe
that this agreement can give our companies synergies beyond the distribution
agreement," says Espen Kvale, CEO of Aqua Bio Technology ASA.

"We are looking forward to the new partnership with Aqua Bio Technology ASA.
From the outset, our mission has been to identify and introduce new innovative
products and treatments to promote health and wellbeing for the Nordic
consumers. Moana Skincare, as a certified organic skincare line, is therefore
well-suited for our customers and market, " says Lone Henriksen, CEO of Galaxa
Pharma Aps.

For further information, please contact Espen Kvale, CEO, telephone +47 916 28
092

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
effective and they provide the cosmetics industry with natural alternatives to
traditional ingredients. ABT is also marketing and distributing natural skin
care products developed by partners towards consumers and professional users.
ABT's focus on commercialization and development of natural ingredients and
natural skin care products has been, and will continue to be, an important part
of the company's strategy going forward. Aqua Bio Technology is listed on
Euronext Expand.

This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.

 

 

 

 

DISCLAIMER

This information is subject of the disclosure requirements pursuant to section
of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

 * Espen Kvale, CEO, +47 916 28 092, espen.kvale@aquabiotech.no 

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

 * Download announcement as PDF.pdf
   [https://kommunikasjon.ntb.no/ir-files/17847556/314/380/Download%20announceme
   nt%20as%20PDF.pdf]